Post-transplant lymphoproliferative disease

Common Name(s)

Post-transplant lymphoproliferative disease

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Post-transplant lymphoproliferative disease" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Post-transplant lymphoproliferative disease" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Post-transplant lymphoproliferative disease" returned 26 free, full-text research articles on human participants. First 3 results:

Post-transplant lymphoproliferative disease after liver transplantation.
 

Author(s): José Ignacio Herrero, Carlos Panizo

Journal: Rev Esp Enferm Dig. 2018 02;110(2):131-132.

 

We have read the article "Post-transplant lymphoproliferative disease in liver transplant recipients" with great interest. This article reports a series of liver transplant recipients with post-transplant lymphoproliferative disease (PTLD). The effect on patient survival and the potential ...

Last Updated: 31 Dec 1969

Go To URL
Post-transplant lymphoproliferative disease in liver transplant recipients.
 

Author(s): Mercedes Rubio-Manzanares Dorado, José María Álamo Martínez, Carmen Bernal Bellido, Luis Miguel Marín Gómez, Gonzalo Suárez Artacho, Carmen Cepeda Franco, Jize Wang, Miguel Ángel Gómez Bravo, Francisco Javier Padillo

Journal: Rev Esp Enferm Dig. 2017 Jun;109(6):406-413.

 

Post-transplant lymphoproliferative syndrome (PTLD) is a rare and potentially life-threatening complication after liver transplantation. The aim of this study was to analyze the clinicopathologic features related to PTLD in a single institution after liver transplantation.

Last Updated: 31 Dec 1969

Go To URL
How Should We Treat Early Post-Transplant Lymphoproliferative Disease After Heart Transplantation?
 

Author(s): Daisuke Nitta, Koichiro Kinugawa, Teruhiko Imamura, Masaru Hatano, Minoru Ono, Fumihiko Nakamura, Mineo Kurokawa, Issei Komuro

Journal: Int Heart J. 2015 ;56(6):676-8.

 

Although post-transplant lymphoproliferative disease (PTLD) is one of the major fatal complications encountered several years after heart transplant (HTx), little is known about early-PTLD emerging within the first year. We here describe the rare case of a 24-year-old female patient ...

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Post-transplant lymphoproliferative disease" returned 6 free, full-text review articles on human participants. First 3 results:

FDG-PET/CT in abdominal post-transplant lymphoproliferative disease.
 

Author(s): Ur Metser, Glen Lo

Journal: Br J Radiol. 2016 ;89(1057):20150844.

 

Post-transplant lymphoproliferative disease (PTLD) is a major cause of morbidity and mortality following both solid organ and haematopoietic stem cell transplantation. PTLD has a broad range of manifestations with extranodal involvement more common in the abdomen than nodal involvement. ...

Last Updated: 31 Dec 1969

Go To URL
Rabbit antithymocyte globulin induction and risk of post-transplant lymphoproliferative disease in adult and pediatric solid organ transplantation: An update.
 

Author(s): Alexandre Hertig, Andreas Zuckermann

Journal: Transpl. Immunol.. 2015 Jun;32(3):179-87.

 

The most modifiable risk factor for post-transplant lymphoproliferative disease (PTLD) is the type and dose of induction and maintenance immunosuppressive therapy. It is challenging to identify the contribution of a single agent such as rabbit antithymocyte globulin (rATG) in the ...

Last Updated: 31 Dec 1969

Go To URL
Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies.
 

Author(s): Zeina Al-Mansour, Beverly P Nelson, Andrew M Evens

Journal: Curr Hematol Malig Rep. 2013 Sep;8(3):173-83.

 

Post-transplant lymphoproliferative diseases (PTLD) are heterogeneous lymphoid disorders ranging from indolent polyclonal proliferations to aggressive lymphomas that complicate solid organ or hematopoietic transplantation. Risk factors for PTLD include viral infections, degree of ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With Rituximab SC and Immunochemotherapy
 

Status: Recruiting

Condition Summary: Posttransplant Lymphoproliferative Disorder

 

Last Updated: 26 Feb 2017

Go to URL
Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant
 

Status: Not yet recruiting

Condition Summary: Post-transplant Lymphoproliferative Disease; Transplant-Related Hematologic Malignancy

 

Last Updated: 24 Oct 2017

Go to URL
Tabelecleucel for Allogeneic Hematopoietic Cell Transplant Subjects With EBV+ PTLD After Failure of Rituximab
 

Status: Recruiting

Condition Summary: Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder

 

Last Updated: 9 May 2018

Go to URL